Institutional investors hold a majority ownership of AMGN through the 82.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB Bought 1.5 Million shares of Amgen
RUSSELL INVESTMENT MANAGEMENT LL... Bought 1.3 Million shares of Amgen
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.1 Million shares of Amgen